Parker VER, Hoang T, Schlichthaar H, Gibb FW, et al. Efficacy and safety of cotadutide, a dual GLP-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab 2022 Apr 11. doi: 10.1111/dom.14712.
PMID: 35403793